肝癌局部区域治疗：钇-90（Y-90）选择性体内放射疗法（SIRT）。 - Suppr

Suppr

超能文献

HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT).

作者信息

Güney İsa Burak

机构信息

Nuclear Medicine Department, Faculty of Medicine, Çukurova University, Adana, Turkey.

出版信息

J Gastrointest Cancer. 2017 Sep;48(3):276-280. doi: 10.1007/s12029-017-9973-2.

DOI:10.1007/s12029-017-9973-2

PMID:28634672

Abstract

摘要

相似文献

HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT).肝癌局部区域治疗：钇-90（Y-90）选择性体内放射疗法（SIRT）。

J Gastrointest Cancer. 2017 Sep;48(3):276-280. doi: 10.1007/s12029-017-9973-2.

Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.不可切除肝细胞癌的治疗选择，重点是使用钇-90树脂微球的选择性内放射治疗（SIRT）

Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30.

Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.肝肿瘤选择性内放射治疗后放射性微球诱导的胃肠道溃疡：一种未被充分认识的临床实体。

Gastrointest Endosc. 2009 Sep;70(3):561-7. doi: 10.1016/j.gie.2009.03.015. Epub 2009 Jul 4.

Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.选择性肝内钇-90放射性栓塞治疗（90Y-SIRT）与最佳支持治疗对全身治疗难治的不可切除转移性黑色素瘤肝转移患者的疗效比较：安全性和有效性队列研究

Am J Clin Oncol. 2017 Feb;40(1):27-34. doi: 10.1097/COC.0000000000000109.

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis.选择性内放射治疗与索拉非尼治疗门静脉血栓形成的肝细胞癌的比较。

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):635-43. doi: 10.1007/s00259-015-3210-7. Epub 2015 Oct 12.

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma.不可切除肝细胞癌选择性内放射治疗与化疗栓塞的初步随机试验

Liver Int. 2015 Jun;35(6):1715-21. doi: 10.1111/liv.12750. Epub 2015 Jan 17.

Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.钇-90 选择性体内放射治疗完全根除结直肠癌肝转移灶

World J Gastroenterol. 2007 Jun 7;13(21):3016-9. doi: 10.3748/wjg.v13.i21.3016.

[Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].[肝癌的选择性内放疗（放射性栓塞）与放射治疗——现状与展望]

Z Gastroenterol. 2009 Jan;47(1):37-54. doi: 10.1055/s-2008-1028002. Epub 2009 Jan 20.

Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.选择性内照射治疗单次给药与索拉非尼持续治疗用于局部晚期肝细胞癌的对比研究（SIRveNIB）：一项III期随机对照试验的研究方案

BMC Cancer. 2016 Nov 7;16(1):856. doi: 10.1186/s12885-016-2868-y.

Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.钇-90 选择性内照射治疗对非传统肝脏肿瘤的影响。

World J Gastroenterol. 2015 Jul 21;21(27):8271-83. doi: 10.3748/wjg.v21.i27.8271.

引用本文的文献

The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment.肝脏最大容量测试（LiMAx）与接受经动脉治疗的早期肝癌患者的短期生存相关。

Cancers (Basel). 2022 Oct 28;14(21):5323. doi: 10.3390/cancers14215323.

Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma.钇-90 选择性内放射治疗不可切除肝细胞癌的疗效和安全性。

BMC Gastroenterol. 2021 May 12;21(1):216. doi: 10.1186/s12876-021-01805-6.

本文引用的文献

(68)Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma.（68）镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像在原发性肝细胞癌中的应用

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):795-6. doi: 10.1007/s00259-015-3297-x. Epub 2016 Jan 8.

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理

J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.

Hepatocellular carcinoma.肝细胞癌

N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.

General selection criteria of patients for radioembolization of liver tumors: an international working group report.肝脏肿瘤放射性栓塞治疗的患者一般选择标准：国际工作组报告。

Am J Clin Oncol. 2011 Jun;34(3):337-41. doi: 10.1097/COC.0b013e3181ec61bb.

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.索拉非尼在亚太地区晚期肝细胞癌患者中的疗效和安全性：一项III期随机、双盲、安慰剂对照试验。

Lancet Oncol. 2009 Jan;10(1):25-34. doi: 10.1016/S1470-2045(08)70285-7. Epub 2008 Dec 16.

Liver disease induced by radioembolization of liver tumors: description and possible risk factors.肝肿瘤放射性栓塞诱导的肝病：描述及可能的危险因素。

Cancer. 2008 Apr 1;112(7):1538-46. doi: 10.1002/cncr.23339.

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.使用钇-90微球近距离放射治疗进行肝恶性肿瘤放射性栓塞治疗的建议：放射性栓塞近距离放射治疗肿瘤学联盟的共识小组报告

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):13-23. doi: 10.1016/j.ijrobp.2006.11.060.

Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.钇-90微球（TheraSphere）治疗不可切除肝细胞癌：降期至可切除、射频消融及作为肝移植的桥梁

J Surg Oncol. 2006 Dec 1;94(7):572-86. doi: 10.1002/jso.20609.

Management of hepatocellular carcinoma.肝细胞癌的管理

Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.

Global cancer statistics, 2002.2002年全球癌症统计数据。

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验